Hospitals Should Adopt Protocols to Support Trainees Against Discrimination
Article offers 5 concrete protocols for supporting trainees when they encounter patient discrimination.
All articles by Pulmonology Advisor Contributing Writer
Tobacco Sale Violations Still Common in FDA Age-Restricted Locations
Nearly 50% of tobacco and vape shops surveyed did not follow FDA regulations in checking identification for persons younger than 27 years.
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH
Inhaled epoprostenol delivered via high-flow nasal cannula increased oxygenation among patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction.
CPAP Use Significantly Reduces Hypersomnia in Elderly Patients
Use of continuous positive airway pressure improved obstructive sleep apnea without any changes in the neurocognitive sphere or blood pressure readings in elderly patients.
Clinical Implications of Nonexpandable Lung in Mesothelioma
The presence of nonexpandable lung can be an independent predictor of mortality in mesothelioma.
Nocturnal Respiratory Rate May Predict Mortality in Older Community-Dwelling Adults
A mean nocturnal respiratory rate of ≥16 breaths per minute was an independent predictor of long-term cardiovascular and all-cause mortality among community-dwelling older men and women.
Kounis Syndrome: Prevalence and Epidemiology in the United States
The overall prevalence of Kounis syndrome in the United States is 1.1% among patients hospitalized for allergic/hypersensitivity/anaphylactic reactions, with a 7.0% rate of all-cause inpatient mortality.
Inoperable Chronic Thromboembolic Pulmonary Hypertension: BPA vs Riociguat
A new meta-analysis evaluated and compared the efficacy and safety of balloon pulmonary angioplasty with that of riociguat therapy in patients with inoperable chronic thromboembolic pulmonary hypertension.
Public Disclosure of New Drug and Biologics Application Filing With the FDA
Investigators sought to determine how frequently information treated as confidential with regard to New Drug Applications or Biologics License Applications is available to the public.
Mepolizumab Eligibility More Likely in Adults vs Kids With Severe Asthma
Children with severe asthma were less likely to be eligible for mepolizumab than adults with severe asthma.
Next post in Asthma
